Director, US Health Economics and Outcomes Research
GSK
Disclosure(s): GSK: employee, Stocks/Bonds (Private Company)
Elizabeth La, PhD, is a Director in the US Health Economics and Outcomes Research team at GSK, supporting research related to respiratory syncytial virus (RSV) disease and vaccination. Prior to joining GSK, Dr. La was an Associate Director of Health Economics at RTI Health Solutions, conducting contract research for a number of pharmaceutical companies. Dr. La has more than 15 years of experience conducting and managing health economics and outcomes research studies, including a range of retrospective data analyses, economic modeling studies, and literature reviews. Her research has been published in several peer-reviewed journals, including Vaccine, Pediatrics, Pharmacoeconomics, and Human Vaccines & Immunotherapeutics, and presented at various professional conferences.